Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ACUR

Acura Pharmaceuticals (CE) (ACUR)

Acura Pharmaceuticals Inc (CE)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:ACUR
日付受信時刻ニュースソース見出しコード企業名
2024/06/0500 : 00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/05/1521 : 00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/05/1505 : 40Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/02/1500 : 53Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/02/0300 : 27Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/01/1107 : 13Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/01/0305 : 23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/01/0305 : 23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/01/0305 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2024/01/0305 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/12/2202 : 01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/12/0704 : 35Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/11/2102 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/11/2102 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/11/2102 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/11/2102 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/11/0401 : 42Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/10/1301 : 05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/09/2605 : 10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/09/0120 : 00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/09/0105 : 10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/08/3105 : 10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/08/1700 : 20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/08/1101 : 17Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/07/2905 : 41Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/07/2900 : 50Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/07/1322 : 00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/07/0103 : 04Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/07/0102 : 00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:ACURAcura Pharmaceuticals Inc (CE)
2023/07/0100 : 53Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ACUR

最近閲覧した銘柄

Delayed Upgrade Clock